Qiaochu Tu
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Fructose 1-phosphate inhibits mannose phosphate isomerase to suppress hepatocellular carcinogenesis.
Fructose 1-phosphate inhibits mannose phosphate isomerase to suppress hepatocellular carcinogenesis.
Journal: Signal transduction and targeted therapy
Published: September 20, 2025
ALDOB/KAT2A interactions epigenetically modulate TGF-β expression and T cell functions in hepatocellular carcinogenesis.
Journal: Hepatology (Baltimore, Md.)
Published: July 06, 2023
Fructose-1,6-Bisphosphate Aldolase B Depletion Promotes Hepatocellular Carcinogenesis Through Activating Insulin Receptor Signaling and Lipogenesis.
Journal: Hepatology (Baltimore, Md.)
Published: January 29, 2021
Polyphenolic Proanthocyanidin-B2 suppresses proliferation of liver cancer cells and hepatocellular carcinogenesis through directly binding and inhibiting AKT activity.
Journal: Redox biology
Published: July 13, 2020
Loss of hepatic aldolase B activates Akt and promotes hepatocellular carcinogenesis by destabilizing the Aldob/Akt/PP2A protein complex.
Journal: PLoS biology
Published: May 27, 2020
Yeast β-D-glucan exerts antitumour activity in liver cancer through impairing autophagy and lysosomal function, promoting reactive oxygen species production and apoptosis.
Journal: Redox biology
Published: January 18, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026